MDM2 and gastric cancer: For example, tRF-Val directly binds to EEF1A1, facilitating the transport of EEF1A1 to the nucleus and enhances its interaction with MDM2, ultimately resulting in the inhibition of the downstream molecular pathways of P53 and promoting gastric cancer progression [35].